• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DBA/2小鼠肿瘤休眠状态进展过程中L5178Y淋巴瘤群体的表型转变。

Phenotypic shifts in the L5178Y lymphoma population during progression of the tumor-dormant state in DBA/2 mice.

作者信息

Trainer D L, Wheelock E F

出版信息

Cancer Res. 1984 Mar;44(3):1063-71.

PMID:6607108
Abstract

We evaluated the phenotypic changes that take place in the L5178Y tumor cell population during the establishment, maintenance, and termination of the L5178Y tumor-dormant state in DBA/2 mice. Since there is considerable variation among DBA/2 mice in the course of the L5178Y tumor-dormant state, analysis of these phenotypic changes required prospective studies on individual mice. Therefore, we developed a partial peritoneal lavage technique which could be performed repeatedly on an individual mouse without killing the mouse and without terminating the tumor-dormant state. The partial peritoneal lavage technique provided cell samples that were quantitatively representative of the entire peritoneal cell contents without altering the relative proportions or total number of host peritoneal cell subpopulations. Tumor cell clones were isolated from the uncloned L5178Y cell inoculum that was used to initiate the tumor-dormant state, and from the partial peritoneal lavage performed on individual mice at regular intervals throughout the tumor-dormant state until each mouse developed an ascitic tumor. We found that the uncloned L5178Y cell population is heterogeneous, with the majority of the cells [approximately 80% of the clonal populations ("original" phenotype)] able to compete as well as the uncloned L5178Y cell population for immune cytolytic T-lymphocyte activity, and a smaller percentage [approximately 20% of the clones ("emergent" phenotype)] competing significantly less but similar to the tumor cell population which grows out as an ascitic tumor at the termination of the tumor-dormant state. However, both "original" and "emergent" phenotypes encompass a range of subpopulations which have the respective characteristics. There was a progressive enrichment in the tumor cell population for "emergent"-phenotype cells as mice progressed through the tumor-dormant state. In the 30-day period prior to tumor emergence, only "emergent"-phenotype cell clones were isolated. These data indicate that, during the course of the tumor-dormant state, there is continual selection by immune cytolytic T-lymphocytes for "emergent"-phenotype cells, which preexist in the L5178Y cell population used to initiate the tumor-dormant state, and that the progressive enrichment of "emergent"-phenotype cells in the peritoneal cavity is associated with and may be responsible for termination of the tumor-dormant state.

摘要

我们评估了在DBA/2小鼠中建立、维持和终止L5178Y肿瘤休眠状态期间L5178Y肿瘤细胞群体发生的表型变化。由于DBA/2小鼠在L5178Y肿瘤休眠状态过程中存在相当大的差异,对这些表型变化的分析需要对个体小鼠进行前瞻性研究。因此,我们开发了一种部分腹膜灌洗技术,该技术可以在不杀死小鼠且不终止肿瘤休眠状态的情况下对个体小鼠重复进行。部分腹膜灌洗技术提供的细胞样本在数量上代表了整个腹膜细胞内容物,而不会改变宿主腹膜细胞亚群的相对比例或总数。从用于启动肿瘤休眠状态的未克隆L5178Y细胞接种物中,以及在整个肿瘤休眠状态期间定期对个体小鼠进行的部分腹膜灌洗中分离肿瘤细胞克隆,直到每只小鼠出现腹水肿瘤。我们发现未克隆的L5178Y细胞群体是异质的,大多数细胞[约80%的克隆群体(“原始”表型)]在免疫细胞溶解T淋巴细胞活性方面与未克隆的L5178Y细胞群体竞争能力相同,而较小比例[约20%的克隆(“新出现”表型)]竞争能力明显较弱,但与在肿瘤休眠状态终止时以腹水肿瘤形式生长的肿瘤细胞群体相似。然而,“原始”和“新出现”表型都包含一系列具有各自特征的亚群。随着小鼠经历肿瘤休眠状态,肿瘤细胞群体中“新出现”表型细胞逐渐富集。在肿瘤出现前的30天内,仅分离出“新出现”表型细胞克隆。这些数据表明,在肿瘤休眠状态过程中,免疫细胞溶解T淋巴细胞持续选择“新出现”表型细胞,这些细胞在用于启动肿瘤休眠状态的L5178Y细胞群体中预先存在,并且“新出现”表型细胞在腹腔中的逐渐富集与肿瘤休眠状态的终止相关,并且可能是其原因。

相似文献

1
Phenotypic shifts in the L5178Y lymphoma population during progression of the tumor-dormant state in DBA/2 mice.DBA/2小鼠肿瘤休眠状态进展过程中L5178Y淋巴瘤群体的表型转变。
Cancer Res. 1984 Mar;44(3):1063-71.
2
Characterization of L5178Y cell phenotypes isolated during progression of the tumor-dormant state in DBA2 mice.对在DBA2小鼠肿瘤休眠状态进展过程中分离出的L5178Y细胞表型的表征。
Cancer Res. 1984 Jul;44(7):2897-906.
3
Enhanced suppressor macrophage activity associated with termination of the L5178Y cell tumor-dormant state in DBA/2 mice.DBA/2小鼠中与L5178Y细胞肿瘤休眠状态终止相关的增强的抑制性巨噬细胞活性。
Cancer Res. 1983 Dec;43(12 Pt 1):5831-6.
4
Immune regulation of the L5178Y murine tumor-dormant state. II. Interferon-gamma requires tumor necrosis factor to restrain tumor cell growth in peritoneal cell cultures from tumor-dormant mice.L5178Y小鼠肿瘤休眠状态的免疫调节。II. 干扰素-γ需要肿瘤坏死因子来抑制来自肿瘤休眠小鼠的腹膜细胞培养物中的肿瘤细胞生长。
J Immunol. 1987 Nov 1;139(9):3146-52.
5
Elimination of L5178Y cells from tumor-dormant DBA/2 mice by specific active immunotherapy.通过特异性主动免疫疗法清除肿瘤休眠DBA/2小鼠中的L5178Y细胞。
Cancer Res. 1983 Jan;43(1):15-21.
6
In vivo lysis of L5178Y cells in the establishment of the tumor-dormant state in DBA/2 mice.在DBA/2小鼠肿瘤休眠状态建立过程中L5178Y细胞的体内裂解
J Immunol. 1980 Apr;124(4):1642-7.
7
Maintenance and cure of the L5178Y murine tumor-dormant state by interleukin 2: in vivo and in vitro effects.
Cancer Res. 1990 Mar 1;50(5):1361-7.
8
Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.L5178Y细胞上的交叉反应抗原,在肿瘤休眠状态建立过程中作为细胞毒性T淋巴细胞裂解的靶标。
Cancer Res. 1982 Sep;42(9):3607-16.
9
Rapidly reversible resistance to immune lysis of L5178Y lymphoma cells in a tumor-dormant state in DBA/2 mice.DBA/2小鼠肿瘤休眠状态下L5178Y淋巴瘤细胞对免疫裂解的快速可逆性抗性
J Natl Cancer Inst. 1986 Jun;76(6):1199-204.
10
Establishment and control of the L5178Y-cell tumor dormant state in DBA/2 mice.DBA/2小鼠中L5178Y细胞肿瘤休眠状态的建立与调控
Cancer Metastasis Rev. 1982;1(1):29-44. doi: 10.1007/BF00049479.

引用本文的文献

1
Implications of tumor progression on clinical oncology.肿瘤进展对临床肿瘤学的影响。
Clin Exp Metastasis. 1985 Jul-Sep;3(3):151-88. doi: 10.1007/BF01786761.
2
Immune regulation of the L5178Y murine tumor-dormant state. I. In vivo and in vitro effects of prostaglandin E2 and indomethacin on tumor cell growth.L5178Y小鼠肿瘤休眠状态的免疫调节。I. 前列腺素E2和吲哚美辛对肿瘤细胞生长的体内和体外作用。
J Exp Med. 1986 Oct 1;164(4):1259-73. doi: 10.1084/jem.164.4.1259.